Novel therapeutics for nephrotic syndrome (2012)

Posted on May 28, 2012 by chugh

The potential of novel sialylation-based therapeutics using N-acetyl-D-mannosamine (ManNAc) for Minimal Change Disease and Diabetic Nephropathy received extensive coverage at the Eupopean Nephrology Meeting (ERA EDTA) in Paris in May 2012.